Medicines and Healthcare products Regulatory Agency fee increases

European Medicines AgencyFees
Written By Elisabethann Wright

The Medicines and Healthcare products Regulatory Agency (MHRA) has increased fees in a number of areas by an average of 8%. The fees entered into application on April 1, 2025 (https://www.gov.uk/government/publications/mhra-fees/current-mhra-fees). To address concerns regarding the implications of the fees for Small and Medium-Sized Enterprises (SMEs) the MHRA will create a new SME payment easement which will permit SMEs to pay fees in two installments. The MHRA will provide more details on this "in due course."

Elisabethann Wright
Previous

The European Court of Justice clarifies different definitions of a medicinal product and a medical device
Next

European Health Data Space Regulation enters into force